APO Research
Talk to an analyst

APO RESEARCH · REPORT

C1-INH Replacement Therapy

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global C1-INH Replacement Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

28 December 2025175 pages

Choose your research edition.

Industry ResearchC1-INH Replacement Therapy Industry Research Report 2026101 pages · $2,950 USDIndustry Growth & TrendsGlobal C1-INH Replacement Therapy Industry Growth and Trends Forecast to 203261 pages · $3,450 USDMarket StructureGlobal C1-INH Replacement Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032175 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal C1-INH Replacement Therapy Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal C1-INH Replacement Therapy Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global C1-INH Replacement Therapy market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for C1-INH Replacement Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for C1-INH Replacement Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for C1-INH Replacement Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for C1-INH Replacement Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of C1-INH Replacement Therapy include CSL Behring, Pharming Healthcare and Takeda, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global C1-INH Replacement Therapy market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of C1-INH Replacement Therapy and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents C1-INH Replacement Therapy revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the C1-INH Replacement Therapy market size, projected growth trends, production technologies, key applications, and end-use industries.

C1-INH Replacement Therapy Segment by Company

CSL Behring

Pharming Healthcare

Takeda

C1-INH Replacement Therapy Segment by Type

Subcutaneous Injection

Intravenous Injection

C1-INH Replacement Therapy Segment by Application

Acquired Angioedema

Hereditary Angioedema

C1-INH Replacement Therapy Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global C1-INH Replacement Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of C1-INH Replacement Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of C1-INH Replacement Therapy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of C1-INH Replacement Therapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global C1-INH Replacement Therapy industry.

Chapter 3: Detailed analysis of C1-INH Replacement Therapy companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, C1-INH Replacement Therapyrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global C1-INH Replacement Therapy Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Subcutaneous Injection Table 3. Key Players of Intravenous Injection Table 4. Global C1-INH Replacement Therapy Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Acquired Angioedema Table 6. Key Players of Hereditary Angioedema Table 7. Global C1-INH Replacement Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 8. Global C1-INH Replacement Therapy Market Size by Region (2021-2026) & (US$ Million) Table 9. Global C1-INH Replacement Therapy Market Share by Region (2021-2026) Table 10. Global C1-INH Replacement Therapy Market Size by Region (2027-2032) & (US$ Million) Table 11. Global C1-INH Replacement Therapy Market Share by Region (2027-2032) Table 12. C1-INH Replacement Therapy Industry Trends Table 13. C1-INH Replacement Therapy Industry Drivers Table 14. C1-INH Replacement Therapy Industry Opportunities and Challenges Table 15. C1-INH Replacement Therapy Industry Restraints Table 16. Global C1-INH Replacement Therapy Revenue by Company (US$ Million) & (2021-2026) Table 17. Global C1-INH Replacement Therapy Revenue Market Share by Company (2021-2026) Table 18. Global C1-INH Replacement Therapy Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 19. Global C1-INH Replacement Therapy Key Company Head Office and Area Served Table 20. Global C1-INH Replacement Therapy Company, Product Type & Application Table 21. Global C1-INH Replacement Therapy Company Establishment Date Table 22. Global Company Market Concentration Ratio (CR5 and HHI) Table 23. Global C1-INH Replacement Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 24. Global C1-INH Replacement Therapy Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global C1-INH Replacement Therapy Market Size by Type (2021-2026) & (US$ Million) Table 26. Global C1-INH Replacement Therapy Market Size by Type (2027-2032) & (US$ Million) Table 27. Global C1-INH Replacement Therapy Revenue Market Share by Type (2021-2026) Table 28. Global C1-INH Replacement Therapy Revenue Market Share by Type (2027-2032) Table 29. Global C1-INH Replacement Therapy Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global C1-INH Replacement Therapy Market Size by Application (2021-2026) & (US$ Million) Table 31. Global C1-INH Replacement Therapy Market Size by Application (2027-2032) & (US$ Million) Table 32. Global C1-INH Replacement Therapy Revenue Market Share by Application (2021-2026) Table 33. Global C1-INH Replacement Therapy Revenue Market Share by Application (2027-2032) Table 34. CSL Behring Company Information Table 35. CSL Behring Business Overview Table 36. CSL Behring C1-INH Replacement Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. CSL Behring C1-INH Replacement Therapy Product Portfolio Table 38. CSL Behring Recent Development Table 39. Pharming Healthcare Company Information Table 40. Pharming Healthcare Business Overview Table 41. Pharming Healthcare C1-INH Replacement Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Pharming Healthcare C1-INH Replacement Therapy Product Portfolio Table 43. Pharming Healthcare Recent Development Table 44. Takeda Company Information Table 45. Takeda Business Overview Table 46. Takeda C1-INH Replacement Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Takeda C1-INH Replacement Therapy Product Portfolio Table 48. Takeda Recent Development Table 49. North America C1-INH Replacement Therapy Market Size by Type (2021-2026) & (US$ Million) Table 50. North America C1-INH Replacement Therapy Market Size by Type (2027-2032) & (US$ Million) Table 51. North America C1-INH Replacement Therapy Market Size by Application (2021-2026) & (US$ Million) Table 52. North America C1-INH Replacement Therapy Market Size by Application (2027-2032) & (US$ Million) Table 53. North America C1-INH Replacement Therapy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 54. North America C1-INH Replacement Therapy Market Size by Country (2021-2026) Table 55. North America C1-INH Replacement Therapy Market Size by Country (2027-2032) Table 56. Europe C1-INH Replacement Therapy Market Size by Type (2021-2026) & (US$ Million) Table 57. Europe C1-INH Replacement Therapy Market Size by Type (2027-2032) & (US$ Million) Table 58. Europe C1-INH Replacement Therapy Market Size by Application (2021-2026) & (US$ Million) Table 59. Europe C1-INH Replacement Therapy Market Size by Application (2027-2032) & (US$ Million) Table 60. Europe C1-INH Replacement Therapy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 61. Europe C1-INH Replacement Therapy Market Size by Country (2021-2026) Table 62. Europe C1-INH Replacement Therapy Market Size by Country (2027-2032) Table 63. China C1-INH Replacement Therapy Market Size by Type (2021-2026) & (US$ Million) Table 64. China C1-INH Replacement Therapy Market Size by Type (2027-2032) & (US$ Million) Table 65. China C1-INH Replacement Therapy Market Size by Application (2021-2026) & (US$ Million) Table 66. China C1-INH Replacement Therapy Market Size by Application (2027-2032) & (US$ Million) Table 67. Asia C1-INH Replacement Therapy Market Size by Type (2021-2026) & (US$ Million) Table 68. Asia C1-INH Replacement Therapy Market Size by Type (2027-2032) & (US$ Million) Table 69. Asia C1-INH Replacement Therapy Market Size by Application (2021-2026) & (US$ Million) Table 70. Asia C1-INH Replacement Therapy Market Size by Application (2027-2032) & (US$ Million) Table 71. Asia C1-INH Replacement Therapy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 72. Asia C1-INH Replacement Therapy Market Size by Country (2021-2026) Table 73. Asia C1-INH Replacement Therapy Market Size by Country (2027-2032) Table 74. South America, Middle East & Africa C1-INH Replacement Therapy Market Size by Type (2021-2026) & (US$ Million) Table 75. South America, Middle East & Africa C1-INH Replacement Therapy Market Size by Type (2027-2032) & (US$ Million) Table 76. South America, Middle East & Africa C1-INH Replacement Therapy Market Size by Application (2021-2026) & (US$ Million) Table 77. South America, Middle East & Africa C1-INH Replacement Therapy Market Size by Application (2027-2032) & (US$ Million) Table 78. South America, Middle East & Africa C1-INH Replacement Therapy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 79. South America, Middle East & Africa C1-INH Replacement Therapy Market Size by Country (2021-2026) Table 80. South America, Middle East & Africa C1-INH Replacement Therapy Market Size by Country (2027-2032) Table 81. Research Programs/Design for This Report Table 82. Authors List of This Report Table 83. Secondary Sources Table 84. Primary Sources List of Figures Figure 1. C1-INH Replacement Therapy Product Image Figure 2. Global C1-INH Replacement Therapy Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global C1-INH Replacement Therapy Market Share by Type: 2025 VS 2032 Figure 4. Subcutaneous Injection Image Figure 5. Intravenous Injection Image Figure 6. Global C1-INH Replacement Therapy Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global C1-INH Replacement Therapy Market Share by Application: 2025 VS 2032 Figure 8. Acquired Angioedema Image Figure 9. Hereditary Angioedema Image Figure 10. Global C1-INH Replacement Therapy Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global C1-INH Replacement Therapy Market Size (2021-2032) & (US$ Million) Figure 12. Global C1-INH Replacement Therapy Market Share by Region: 2025 VS 2032 Figure 13. Years Considered Figure 14. Global C1-INH Replacement Therapy Market Share by Players in 2025 Figure 15. Global Top 5 and 10 C1-INH Replacement Therapy Players Market Share by Revenue in 2025 Figure 16. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global C1-INH Replacement Therapy Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global C1-INH Replacement Therapy Revenue Market Share by Type (2021-2032) Figure 19. Global C1-INH Replacement Therapy Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global C1-INH Replacement Therapy Revenue Market Share by Application (2021-2032) Figure 21. North America C1-INH Replacement Therapy Market Size (2021-2032) & (US$ Million) Figure 22. North America C1-INH Replacement Therapy Market Share by Type (2021-2032) Figure 23. North America C1-INH Replacement Therapy Market Share by Application (2021-2032) Figure 24. North America C1-INH Replacement Therapy Market Share by Country (2021-2032) Figure 25. United States C1-INH Replacement Therapy Market Size (2021-2032) & (US$ Million) Figure 26. Canada C1-INH Replacement Therapy Market Size (2021-2032) & (US$ Million) Figure 27. Mexico C1-INH Replacement Therapy Market Size (2021-2032) & (US$ Million) Figure 28. Europe C1-INH Replacement Therapy Market Size (2021-2032) & (US$ Million) Figure 29. Europe C1-INH Replacement Therapy Market Share by Type (2021-2032) Figure 30. Europe C1-INH Replacement Therapy Market Share by Application (2021-2032) Figure 31. Europe C1-INH Replacement Therapy Market Share by Country (2021-2032) Figure 32. Germany C1-INH Replacement Therapy Market Size (2021-2032) & (US$ Million) Figure 33. France C1-INH Replacement Therapy Market Size (2021-2032) & (US$ Million) Figure 34. U.K. C1-INH Replacement Therapy Market Size (2021-2032) & (US$ Million) Figure 35. Italy C1-INH Replacement Therapy Market Size (2021-2032) & (US$ Million) Figure 36. Russia C1-INH Replacement Therapy Market Size (2021-2032) & (US$ Million) Figure 37. Nordic Countries C1-INH Replacement Therapy Market Size (2021-2032) & (US$ Million) Figure 38. China C1-INH Replacement Therapy Market Size (2021-2032) & (US$ Million) Figure 39. China C1-INH Replacement Therapy Market Share by Type (2021-2032) Figure 40. China C1-INH Replacement Therapy Market Share by Application (2021-2032) Figure 41. Asia C1-INH Replacement Therapy Market Size (2021-2032) & (US$ Million) Figure 42. Asia C1-INH Replacement Therapy Market Share by Type (2021-2032) Figure 43. Asia C1-INH Replacement Therapy Market Share by Application (2021-2032) Figure 44. Asia C1-INH Replacement Therapy Market Share by Country (2021-2032) Figure 45. Japan C1-INH Replacement Therapy Market Size (2021-2032) & (US$ Million) Figure 46. South Korea C1-INH Replacement Therapy Market Size (2021-2032) & (US$ Million) Figure 47. Taiwan C1-INH Replacement Therapy Market Size (2021-2032) & (US$ Million) Figure 48. Southeast Asia C1-INH Replacement Therapy Market Size (2021-2032) & (US$ Million) Figure 49. India C1-INH Replacement Therapy Market Size (2021-2032) & (US$ Million) Figure 50. Australia C1-INH Replacement Therapy Market Size (2021-2032) & (US$ Million) Figure 51. South America, Middle East & Africa C1-INH Replacement Therapy Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa C1-INH Replacement Therapy Market Share by Type (2021-2032) Figure 53. South America, Middle East & Africa C1-INH Replacement Therapy Market Share by Application (2021-2032) Figure 54. South America, Middle East & Africa C1-INH Replacement Therapy Market Share by Country (2021-2032) Figure 55. Brazil C1-INH Replacement Therapy Market Size (2021-2032) & (US$ Million) Figure 56. South Africa C1-INH Replacement Therapy Market Size (2021-2032) & (US$ Million) Figure 57. Saudi Arabia C1-INH Replacement Therapy Market Size (2021-2032) & (US$ Million) Figure 58. Turkey C1-INH Replacement Therapy Market Size (2021-2032) & (US$ Million) Figure 59. Argentina C1-INH Replacement Therapy Market Size (2021-2032) & (US$ Million) Figure 60. UAE C1-INH Replacement Therapy Market Size (2021-2032) & (US$ Million) Figure 61. Egypt C1-INH Replacement Therapy Market Size (2021-2032) & (US$ Million) Figure 62. Chile C1-INH Replacement Therapy Market Size (2021-2032) & (US$ Million) Figure 63. Research Process Figure 64. Key Executives Interviewed

Scope & coverage.

Types
  • Subcutaneous Injection
  • Intravenous Injection
Applications
  • Acquired Angioedema
  • Hereditary Angioedema
Companies covered
  • CSL Behring
  • Pharming Healthcare
  • Takeda

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global C1-INH Replacement Therapy Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Subcutaneous Injection
  5. 1.2.3 Intravenous Injection
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global C1-INH Replacement Therapy Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Acquired Angioedema
  9. 1.3.3 Hereditary Angioedema
  10. 1.4 Global Market Growth Prospects
  11. 1.5 Global C1-INH Replacement Therapy Growth Trends by Region
  12. 1.5.1 Global C1-INH Replacement Therapy Market Size by Region: 2021 VS 2025 VS 2032
  13. 1.5.2 C1-INH Replacement Therapy Market Size by Region (2021-2026)
  14. 1.5.3 C1-INH Replacement Therapy Market Size by Region (2027-2032)
  15. 1.6 Assumptions and Limitations
  16. 1.7 Study Goals and Objectives
  17. 1.8 Years Considered
2 Global C1-INH Replacement Therapy Market Dynamics
  1. 2.1 C1-INH Replacement Therapy Industry Trends
  2. 2.2 C1-INH Replacement Therapy Industry Drivers
  3. 2.3 C1-INH Replacement Therapy Industry Opportunities and Challenges
  4. 2.4 C1-INH Replacement Therapy Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global C1-INH Replacement Therapy Revenue by Company (2021-2026)
  2. 3.2 Global C1-INH Replacement Therapy Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global C1-INH Replacement Therapy Key Company Head office and Area Served
  4. 3.4 Global C1-INH Replacement Therapy Company, Product Type & Application
  5. 3.5 Global C1-INH Replacement Therapy Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global C1-INH Replacement Therapy Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 C1-INH Replacement Therapy Players Market Share by Revenue in 2025
  9. 3.6.3 2025 C1-INH Replacement Therapy Tier 1, Tier 2, and Tier 3
4 C1-INH Replacement Therapy Market by Type
  1. 4.1 Global C1-INH Replacement Therapy Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global C1-INH Replacement Therapy Market Size by Type (2021-2032)
  3. 4.3 Global C1-INH Replacement Therapy Market Size Share by Type (2021-2032)
5 C1-INH Replacement Therapy Market by Application
  1. 5.1 Global C1-INH Replacement Therapy Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global C1-INH Replacement Therapy Market Size by Application (2021-2032)
  3. 5.3 Global C1-INH Replacement Therapy Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 CSL Behring
  2. 6.1.1 CSL Behring Company Information
  3. 6.1.2 CSL Behring Business Overview
  4. 6.1.3 CSL Behring C1-INH Replacement Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 CSL Behring C1-INH Replacement Therapy Product Portfolio
  6. 6.1.5 CSL Behring Recent Developments
  7. 6.2 Pharming Healthcare
  8. 6.2.1 Pharming Healthcare Company Information
  9. 6.2.2 Pharming Healthcare Business Overview
  10. 6.2.3 Pharming Healthcare C1-INH Replacement Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Pharming Healthcare C1-INH Replacement Therapy Product Portfolio
  12. 6.2.5 Pharming Healthcare Recent Developments
  13. 6.3 Takeda
  14. 6.3.1 Takeda Company Information
  15. 6.3.2 Takeda Business Overview
  16. 6.3.3 Takeda C1-INH Replacement Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Takeda C1-INH Replacement Therapy Product Portfolio
  18. 6.3.5 Takeda Recent Developments
7 North America
  1. 7.1 North America C1-INH Replacement Therapy Market Size (2021-2032)
  2. 7.2 North America C1-INH Replacement Therapy Market Size by Type
  3. 7.2.1 North America C1-INH Replacement Therapy Market Size by Type (2021-2026)
  4. 7.2.2 North America C1-INH Replacement Therapy Market Size by Type (2027-2032)
  5. 7.2.3 North America C1-INH Replacement Therapy Market Share by Type (2021-2032)
  6. 7.3 North America C1-INH Replacement Therapy Market Size by Application
  7. 7.3.1 North America C1-INH Replacement Therapy Market Size by Application (2021-2026)
  8. 7.3.2 North America C1-INH Replacement Therapy Market Size by Application (2027-2032)
  9. 7.3.3 North America C1-INH Replacement Therapy Market Share by Application (2021-2032)
  10. 7.4 North America C1-INH Replacement Therapy Market Size by Country
  11. 7.4.1 North America C1-INH Replacement Therapy Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America C1-INH Replacement Therapy Market Size by Country (2021-2026)
  13. 7.4.3 North America C1-INH Replacement Therapy Market Size by Country (2027-2032)
  14. 7.4.4 North America C1-INH Replacement Therapy Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe C1-INH Replacement Therapy Market Size (2021-2032)
  2. 8.2 Europe C1-INH Replacement Therapy Market Size by Type
  3. 8.2.1 Europe C1-INH Replacement Therapy Market Size by Type (2021-2026)
  4. 8.2.2 Europe C1-INH Replacement Therapy Market Size by Type (2027-2032)
  5. 8.2.3 Europe C1-INH Replacement Therapy Market Share by Type (2021-2032)
  6. 8.3 Europe C1-INH Replacement Therapy Market Size by Application
  7. 8.3.1 Europe C1-INH Replacement Therapy Market Size by Application (2021-2026)
  8. 8.3.2 Europe C1-INH Replacement Therapy Market Size by Application (2027-2032)
  9. 8.3.3 Europe C1-INH Replacement Therapy Market Share by Application (2021-2032)
  10. 8.4 Europe C1-INH Replacement Therapy Market Size by Country
  11. 8.4.1 Europe C1-INH Replacement Therapy Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe C1-INH Replacement Therapy Market Size by Country (2021-2026)
  13. 8.4.3 Europe C1-INH Replacement Therapy Market Size by Country (2027-2032)
  14. 8.4.4 Europe C1-INH Replacement Therapy Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China C1-INH Replacement Therapy Market Size (2021-2032)
  2. 9.2 China C1-INH Replacement Therapy Market Size by Type
  3. 9.2.1 China C1-INH Replacement Therapy Market Size by Type (2021-2026)
  4. 9.2.2 China C1-INH Replacement Therapy Market Size by Type (2027-2032)
  5. 9.2.3 China C1-INH Replacement Therapy Market Share by Type (2021-2032)
  6. 9.3 China C1-INH Replacement Therapy Market Size by Application
  7. 9.3.1 China C1-INH Replacement Therapy Market Size by Application (2021-2026)
  8. 9.3.2 China C1-INH Replacement Therapy Market Size by Application (2027-2032)
  9. 9.3.3 China C1-INH Replacement Therapy Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia C1-INH Replacement Therapy Market Size (2021-2032)
  2. 10.2 Asia C1-INH Replacement Therapy Market Size by Type
  3. 10.2.1 Asia C1-INH Replacement Therapy Market Size by Type (2021-2026)
  4. 10.2.2 Asia C1-INH Replacement Therapy Market Size by Type (2027-2032)
  5. 10.2.3 Asia C1-INH Replacement Therapy Market Share by Type (2021-2032)
  6. 10.3 Asia C1-INH Replacement Therapy Market Size by Application
  7. 10.3.1 Asia C1-INH Replacement Therapy Market Size by Application (2021-2026)
  8. 10.3.2 Asia C1-INH Replacement Therapy Market Size by Application (2027-2032)
  9. 10.3.3 Asia C1-INH Replacement Therapy Market Share by Application (2021-2032)
  10. 10.4 Asia C1-INH Replacement Therapy Market Size by Country
  11. 10.4.1 Asia C1-INH Replacement Therapy Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia C1-INH Replacement Therapy Market Size by Country (2021-2026)
  13. 10.4.3 Asia C1-INH Replacement Therapy Market Size by Country (2027-2032)
  14. 10.4.4 Asia C1-INH Replacement Therapy Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa C1-INH Replacement Therapy Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa C1-INH Replacement Therapy Market Size by Type
  3. 11.2.1 South America, Middle East & Africa C1-INH Replacement Therapy Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa C1-INH Replacement Therapy Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa C1-INH Replacement Therapy Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa C1-INH Replacement Therapy Market Size by Application
  7. 11.3.1 South America, Middle East & Africa C1-INH Replacement Therapy Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa C1-INH Replacement Therapy Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa C1-INH Replacement Therapy Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa C1-INH Replacement Therapy Market Size by Country
  11. 11.4.1 South America, Middle East & Africa C1-INH Replacement Therapy Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa C1-INH Replacement Therapy Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa C1-INH Replacement Therapy Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa C1-INH Replacement Therapy Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst